The relation between human lysosomal beta-galactosidase and its protective protein

Area of Science:

• Lysosomal storage diseases
• Molecular genetics
• Enzyme biochemistry

Background:

• Galactosialidosis is a lysosomal storage disease characterized by combined beta-galactosidase and sialidase deficiency.
• Cultured fibroblasts from galactosialidosis patients lack a specific 54-kDa precursor protein, essential for enzyme stability.

Purpose of the Study:

• To elucidate the mechanism of lysosomal beta-galactosidase protection against proteolytic degradation.
• To investigate the role of the 54-kDa protective protein in enzyme stability and complex formation.

Main Methods:

• Sucrose density gradient centrifugation to analyze enzyme molecular weight.
• Immunoprecipitation studies to identify protein interactions.
• Cultured skin fibroblast analysis from normal and galactosialidosis patients.

Main Results:

• Normal fibroblasts show beta-galactosidase as a high molecular weight multimer (600-700 kDa) at lysosomal pH, while galactosialidosis cells exhibit only monomeric forms.
• The 54-kDa protective protein precursor is absent in galactosialidosis fibroblasts.
• Addition of the protective protein precursor normalizes beta-galactosidase aggregation in galactosialidosis cells.
• Protective protein is associated with the multimeric form of beta-galactosidase.

Conclusions:

• A high molecular weight complex of beta-galactosidase, sialidase, and protective protein protects against lysosomal proteolysis.
• Genetic deficiency of the protective protein leads to rapid degradation of monomeric beta-galactosidase and loss of sialidase activity.
• This study clarifies the protective mechanism for key lysosomal enzymes in galactosialidosis.